Hamza Hassan

Boston University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (15)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (4)

Vaishali Sanchorawala

Boston University School of Medicine

UNITED STATES

View details

Nathanael Fillmore

Assistant Professor of Medicine

Harvard Medical School

UNITED STATES

View details

Camille V Edwards

Assistant Professor of Medicine

Boston University School of Medicine

UNITED STATES

View details

John Sloan

Associate Professor

Boston University School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hamza Hassan

Research Interests

Explore related searches

Contact this professor

Articles (15)

The Impact of Melphalan Conditioning and CD34+ Cell Dose and Schedule on Post‐Transplant Outcomes in AL Amyloidosis

A model for predicting day-100 stem cell transplant-related mortality in AL amyloidosis

Deciphering the response to BCMA CAR T cell therapy

Long‐term outcomes of renal AL amyloidosis patients undergoing autologous stem cell transplantation: Validating the performance of the renal staging system

Lymphoplasmacytic lymphoma and multiple myeloma coexisting in the same patient: a case series and literature review

Peripheral blood monocyte count is a dynamic prognostic biomarker in multiple myeloma.

More intensive therapy as more effective treatment for frail patients with multiple myeloma

Validation of algorithms to select patients with multiple myeloma and patients initiating myeloma treatment in the national Veterans Affairs Healthcare System.

Modified High-Dose versus High-Dose Melphalan Conditioning in Older Patients Undergoing Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis

Beyond Survival in AL amyloidosis: Identifying and Satisfying Patients’ Needs

Progress in research: Daratumumab improves treatment outcomes of patients with AL amyloidosis

Effect of ibrutinib on humoral dysfunction in patients with chronic lymphocytic leukemia: A single-center experience

Genetic predictors of mortality in patients with multiple myeloma

Role and mechanism of autophagy-regulating factors in tumorigenesis and drug resistance

Safety, Tolerability, and Efficacy of Selinexor in a Patient With Relapsed Light Chain (AL) Amyloidosis

Collaborators (4)

Vaishali Sanchorawala

Nathanael Fillmore

Camille V Edwards

John Sloan

Make your next move.